[e-mail]

ViroPharma: Lev Acquisition Appraisal

Your article missed the mark by a wide margin. Number one, its incredibly ignorant to assume a. someone can "feel" an attack coming and b. That they would want to have the attack in the first place and just catch it early. These attacks can be debilitating, grotesque and deadly. Some patients are severe enough they they would rather treat as a preventitive and as the lev trial showed, when they do get breakthrough attacks they tend to be much less severe. Other people that only get an attack once every few months, of course it would make less sense to treat prophylactically. Whatever your background may be I think you should read a few less "Analyst" reports and read more about the disease before using migraine as your comparable.

Lev Acquisition Looks Good but More Clarity Needed

What's to clarify about the milestone payments? They were detailed in the press release and straight forward.